Industry

DUBLIN–(BUSINESS WIRE)–The “Global Health & Hygiene Market: Analysis By Category (Personal Care and Tissue), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2027” report has been added to ResearchAndMarkets.com’s offering. In the context of living a healthy life, the phrases health and cleanliness are synonymous. Health is a state … [Read more…]

HELSINKI–(BUSINESS WIRE)–TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces that the first US patient has been dosed in its ovarian cancer trial (NCT05271318), using its oncolytic adenovirus, TILT-123, that has the potential to be first-in-class for this indication. This open-label, phase I, dose-escalation, multicenter, and multinational, clinical trial of TILT-123 in combination with … [Read more…]

– Oral and Poster Presentations to Highlight Preclinical Research for ARCUS® Gene Editing DURHAM, N.C.–(BUSINESS WIRE)–$DTIL #ARCUS–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that three abstracts have been accepted by the European Society of Gene & … [Read more…]

GENT, Belgium & AMSTERDAM–(BUSINESS WIRE)–#IVD–Fujirebio Europe and Self-screen B.V. today announce a commercial collaboration around the distribution of the PreCursor-M+ methylation-specific molecular IVD assay from Self-screen B.V. The test is intended for the qualitative detection of elevated methylation levels of cervical cancer biomarkers and may be used as a triage follow-up test of human papillomavirus … [Read more…]

ONI’s Super-resolution Nanoimager will be used to identify predictive CAR-T biomarkers and characteristics related to treatment outcomes SAN DIEGO & OXFORD, England–(BUSINESS WIRE)–ONI, a single-molecule imaging platform biotech, today announced a research collaboration with the University of Pennsylvania, one of the true pioneers of CAR-T (chimeric antigen t-cell) research and clinical trials. The collaboration aims … [Read more…]

Clinical data demonstrating initial safety and efficacy from the RESKUE trial are being presented by Chief Medical Officer Maria Escolar, M.D., at the 29th Congress of European Society of Gene & Cell Therapy (ESGCT), October 11-14, 2022 Subjects treated with FBX-101 have shown increased galactocerebrosidase (GALC) enzyme activity in plasma and cerebrospinal fluid (CSF), normal … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–#IDGC2022–International Day of the Girl Child (IDGC) 2022 has arrived! AIDS Healthcare Foundation (AHF) will hold “Our Rights, Our Future”-themed events worldwide that will educate and empower girls to succeed by taking control of their health! At least 129 million girls worldwide are not attending school, an issue exacerbated by inadequate access to … [Read more…]

Established Industry Leader Rachel King will Serve as BIO’s Interim Leader WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. … [Read more…]

SHAWNEE, Kan.–(BUSINESS WIRE)–Strengthening its commitment to building a robust scientific ecosystem and investing in supporting early career scientists, BioKansas has developed a community laboratory to serve students and adult learners interested in obtaining entry-level positions in the bioscience industry. This effort, developed in partnership with industry companies, provides hands-on, industry-relevant, technical training to increase the … [Read more…]

BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2022 results on Tuesday, November 8, 2022. The Company will host a conference call on Tuesday, November 8, 2022, at 10:00 a.m. ET to discuss these results. To access the call, … [Read more…]